Serial measurement of serum C-reactive protein levels can identify patients at risk for severe complications following autologous stem cell transplantation

Leukemia and Lymphoma

Volumn 46, Issue 8, 2005, Pages 1159-1161

  Fassas, Athanasios B T ^a   Miceli, M H ^a   Grazzlutti, M ^a   Dong, L ^a   Barlogie, B ^a   Anaissie, E ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Autologous transplantation; C reactive protein; C reactive protein velocity; Severe complications

Indexed keywords

C REACTIVE PROTEIN; MELPHALAN;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BACTEREMIA; CLINICAL TRIAL; COLITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DRUG INDUCED DISEASE; FEBRILE NEUTROPENIA; HIGH RISK POPULATION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; NEUTROPENIA; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; VALIDATION PROCESS;

C-REACTIVE PROTEIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MULTIPLE MYELOMA; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 23144457060     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500086121     Document Type: Article

References (9)

1. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993;91:1351-1357.
2. Rintala E, Irjala K, Nikoskelainen J. Value of measurement of C-reactive protein in febrile patients with hematological malignancies. Eur J Clin Microbiol Infect Dis 1992;11:973-978.
3. Santolaya ME, Cofre J, Bereis V. C-reactive protein: a valuable aid for the management of febrile children with cancer and neutropenia. Clin Infect Dis 1994;18:589-595.
4. Engel A, Mack E, Kern P, Kern WV. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection 1998;26:213-221.
5. Yonemori K, Kanda Y, Yamamoto R, Hamaki T, Suguro M, Chizuka A, Matsuyama T, Takezako N, Miwa A, Togawa A. Clinical value of serial measurement of serum C-reactive protein level in neutropenic patients. Leuk Lymphoma 2001;41:607-614.
6. Shaughnessy Jr. J, Tian E, Sawyer J, McCoy J, Tricot G, Jacobson J, Anaissie E, Zangari M, Fassas A, Muwalla F et al. Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II. Br J Haematol 2003;120:44-52.
7. Manian FA. A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia. Clin Infect Dis 1995;21:114-121.
8. Ortega M, Rovira M, Almela M, De La Bellacasa JP, Carreras E, Mensa J. Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantation. Bone Marrow Transplant 2004;33:741-744.
9. Donnelly JP, Muus P, Horrevorts AM, Sauerwein RW, De Pauw BE. Failure of clindamycin to influence the course of severe oromucositis associated with streptoccal bacteraemia in allogeneic bone marrow transplant recipients. Scand J Infect Dis 1993;25:43-50.